Detection of somatic β-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD)

Tadjine, Mimi; Lampron, Antoine; Ouadi, Lydia; Horvath, Anelia; Stratakis, Constantine A.; Bourdeau, Isabelle

doi:10.1111/j.1365-2265.2008.03273.x

Cited by 108Adrenal and Paraganglionic TumorsPituitary Gland Disorders and TreatmentsGenetic factors in colorectal cancer

Detection of somatic β-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD)

Open access

Tadjine, Mimi, Lampron, Antoine, Ouadi, Lydia, Horvath, Anelia, Stratakis, Constantine A., Bourdeau, Isabelle·2008·Clinical Endocrinology

DOI 10.1111/j.1365-2265.2008.03273.xPMC PMC3138207

Open this paper in CoChat — free account

Abstract

BACKGROUND: Primary pigmented nodular adrenocortical disease (PPNAD) leads to Cushing syndrome (CS) and is often associated with Carney complex (CNC). Genetic alterations of the type 1-alpha regulatory subunit of cAMP-dependent protein kinase A (PRKAR1A) and phosphodiesterase 11A4 (PDE11A) genes have been found in PPNAD. Recent studies have demonstrated that beta-catenin mutations are frequent in adrenocortical adenomas and carcinomas and that the Wnt-signalling pathway is involved in PPNAD tumorigenesis. We hypothesized that adrenocortical adenomas that form in the context of PPNAD may harbour beta-catenin mutations. METHODS: We studied 18 patients with CS secondary to PPNAD who were screened for germline PRKAR1A and PDE11A mutations. Tumor DNA was extracted from pigmented adrenocortical adenoma and nodular adrenal hyperplasia. Mutation analysis of exons 3 and 5 of beta-catenin was performed using polymerase chain reaction and direct sequencing. Sections from formalin-fixed, paraffin-embedded tumour samples were studied by immunohistochemistry with an antibody against beta-catenin. RESULTS: Nine patients were carrying germline PRKAR1A mutations and one patient had a PDE11A mutation. We found somatic beta-catenin mutations in 2 of 18 patients (11%). In both cases, the mutations occurred in relatively large adenomas that had formed in the background of PPNAD. Tumor DNA analysis revealed a heterozygous ACC-to-GCC missense mutation in codon 41 (T41A) and a TCT-to-CCT missense mutation in codon 45 (S45P) of exon 3 of the beta-catenin gene that was confirmed at the cDNA level. There were no alterations in the DNA of PPNAD-adjacent tissues and lymphocytes from the patients, indicating somatic events. Immunohistochemistry showed nuclear accumulation of beta-catenin in more than 90% of cells in adenomatous tissue whereas no nuclear immunoreactivity was detected in adjacent PPNAD nodular cells. Nuclear translocation of beta-catenin protein in the PPNAD adenoma suggests activation of the Wnt-beta-catenin pathway in PPNAD. CONCLUSIONS: We report, for the first time, beta-catenin mutations in adenomas associated with PPNAD, further implicating Wnt-beta-catenin signalling in tumorigenesis linked to bilateral adrenal hyperplasias.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2008.03273.x

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Activating point mutations in CTNNB1 are identified in over 25% of both ACAs and ACCs in children and adults.
“mutational analysis of the effector of the canonical Wnt pathway, the β-catenin gene, CTNNB1, has identified activating point mutations in over 25% of both ACAs and ACCs in children and adults (149, 206–208).”
From Adrenocortical carcinoma (2014) · cites this paper as [207]
Mutational analysis of CTNNB1 identified activating point mutations in both ACAs and ACCs.
“Furthermore, mutational analysis of the β-catenin gene CTNNB1 identified activating point mutations in both ACAs and ACCs (149, 206–208).”
From Adrenocortical carcinoma (2014) · cites this paper as [207]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566 · see citing works
Wnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666 · see citing works
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601 · see citing works
Wnt signaling and cancer
Polakis, P. (2000) · Genes & Development · doi:10.1101/gad.14.15.1837 · Cited by 3,183 · see citing works
WNT and β-catenin signalling: diseases and therapies
Moon, R. T., Kohn, A. D., Ferrari, G. V. D., & Kaykas, A. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1427 · Cited by 1,763 · see citing works
Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex
Kirschner, L. S., Carney, J. A., Pack, S. D., Taymans, S. E., Giatzakis, C., Cho, Y. S., Cho-Chung, Y. S., & Stratakis, C. A. (2000) · Nature Genetics · doi:10.1038/79238 · Cited by 1,153 · see citing works
Self-citation
Clinical and Molecular Features of the Carney Complex: Diagnostic Criteria and Recommendations for Patient Evaluation
Stratakis, C. A., Kirschner, L. S., & Carney, J. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7903 · Cited by 805 · see citing works
Self-citation
Wnt signaling in the intestinal epithelium: from endoderm to cancerPreprint
Gregorieff, A., & Clevers, H. C. (2005) · Genes & Development · doi:10.1101/gad.1295405 · Cited by 680 · see citing works
β-Catenin destruction complex: insights and questions from a structural perspective
Kimelman, D., & Xu, W. (2006) · Oncogene · doi:10.1038/sj.onc.1210055 · Cited by 628 · see citing works
β-Catenin mutations in cell lines established from human colorectal cancers
Ilyas, M., Tomlinson, I. P. M., Rowan, A., Pignatelli, M. N., & Bodmer, W. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10330 · Cited by 494 · see citing works
Mutations of β-Catenin in Adrenocortical Tumors: Activation of the Wnt Signaling Pathway Is a Frequent Event in both Benign and Malignant Adrenocortical Tumors
Tissier, F., Cavard, C., Groussin, L., Perlemoine, K., Fumey, G., Hagneré, A.-M., René-Corail, F., Jullian, E., Gicquel, C., Bertagna, X., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0593 · Cited by 474 · see citing works
Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex
Kirschner, L. S. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.20.3037 · Cited by 406 · see citing works
Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis
Giordano, T. J., Thomas, D. G., Kuick, R., Lizyness, M., Misek, D. E., Smith, A. L., Sanders, D., Aljundi, R. T., Gauger, P. G., Thompson, N. W., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63846-1 · Cited by 383 · see citing works
A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia
Horvath, A., Boikos, S., Giatzakis, C., Robinson-White, A., Groussin, L., Griffin, K. J., Stein, E., Levine, E., Delimpasi, G., Hsiao, H. P., et al. (2006) · Nature Genetics · doi:10.1038/ng1809 · Cited by 352 · see citing works
Self-citation
Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins
Chen, A. E., Ginty, D. D., & Fan, C.-M. (2005) · Nature · doi:10.1038/nature03126 · Cited by 309 · see citing works
Tumor formation by genetic mutations in the components of the Wnt signaling pathway
Kikuchi, A. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01424.x · Cited by 258 · see citing works
The links between axin and carcinogenesis
Salahshor, S., & Woodgett, J. R. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.009506 · Cited by 250 · see citing works
Paradoxical Response to Dexamethasone in the Diagnosis of Primary Pigmented Nodular Adrenocortical Disease
Stratakis, C. A., Sarlis, N. J., Kirschner, L. S., Carney, J. A., Doppman, J. L., Nieman, L. K., Chrousos, G. P., & Papanicolaou, D. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-8-199910190-00006 · Cited by 244 · see citing works
Self-citation
Frequent mutations of β‐catenin gene in sporadic secreting adrenocortical adenomas*
Tadjine, M., Lampron, A., Ouadi, L., & Bourdeau, I. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03033.x · Cited by 153 · see citing works
Self-citation
Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators
Bourdeau, I., Antonini, S. R. R., Lacroix, A., Kirschner, L. S., Matyakhina, L., Lorang, D., Libutti, S. K., & Stratakis, C. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207277 · Cited by 130 · see citing works
Self-citation
Adrenal Hyperplasia and Adenomas Are Associated with Inhibition of Phosphodiesterase 11A in Carriers of PDE11A Sequence Variants That Are Frequent in the Population
Horvath, A., Giatzakis, C., Robinson-White, A. J., Boikos, S. A., Levine, E., Griffin, K., Stein, E. V., Kamvissi, V., Soni, P., Bossis, I., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2914 · Cited by 112 · see citing works
Self-citation
Characterisation of the phosphorylation of β-catenin at the GSK-3 priming site Ser45
Hagen, T., & Vidal‐Puig, A. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00485-0 · Cited by 110 · see citing works
Primary Pigmented Nodular Adrenocortical Disease: Paradoxical Responses of Cortisol Secretion to Dexamethasone Occur in Vitro and Are Associated with Increased Expression of the Glucocorticoid Receptor
Bourdeau, I., Lacroix, A., Schürch, W., Caron, P. J., Antakly, T., & Stratakis, C. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-022001 · Cited by 106 · see citing works
Self-citation
Bilateral Adrenal Cushing's Syndrome: Macronodular Adrenal Hyperplasia and Primary Pigmented Nodular Adrenocortical Disease
Lacroix, A., & Bourdeau, I. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.004 · Cited by 90 · see citing works
Self-citation
Adrenocortical Tumors, Primary Pigmented Adrenocortical Disease (PPNAD)/Carney Complex, and other Bilateral Hyperplasias: The NIH Studies
Stratakis, C. A. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-981477 · Cited by 62 · see citing works
Self-citation
Adrenocorticotropic hormone-independent Cushing's syndrome
Bourdeau, I., Lampron, A., Costa, M. H. S., Tadjine, M., & Lacroix, A. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32814db842 · Cited by 39 · see citing works
Self-citation
Clinical and Molecular Genetic Studies of Bilateral Adrenal Hyperplasias
Bourdeau, I. (2004) · Endocrine Research · doi:10.1081/erc-200043735 · Cited by 17 · see citing works
Self-citation

Flagged first, then by citations

Sorted by citations

Adrenocortical carcinoma
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892 · see citing works
Constitutive β-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development
Berthon, A. S., Sahut‐Barnola, I., Lambert-Langlais, S., de Joussineau, C., Damon‐Soubeyrand, C., Louiset, E., Taketo, M. M., Tissier, F., Bertherat, J. Y., Lefrançois‐Martinez, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq029 · Cited by 239 · see citing works
WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production
Berthon, A. S., Drelon, C., Ragazzon, B., Boulkroun, S., Tissier, F., Amar, L., Samson-Couterie, B., Zennaro, M., Plouin, P., Skah, S., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt484 · Cited by 207 · see citing works
Cushing's syndrome
Gadelha, M. R., Gatto, F., Wildemberg, L. E., & Fleseriu, M. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01961-x · Cited by 183 · see citing works
Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin
Heaton, J. H., Wood, M. A., Kim, A. C., Lima, L. O., Barlaskar, F. M., Almeida, M. Q., Fragoso, M. C. B. V., Kuick, R., Lerario, A. M., Simon, D. P., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.05.026 · Cited by 173 · see citing works
The Wnt/beta-catenin pathway in adrenocortical development and cancer
El Wakil, A., & Lalli, E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.11.014 · Cited by 134 · see citing works
Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors
Bonnet, S., Gaujoux, S., Launay, P., Baudry, C., Chokri, I., Ragazzon, B., Libé, R., René-Corail, F., Audebourg, A., Vacher-Lavenu, M.-C., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1885 · Cited by 133 · see citing works
PKA inhibits WNT signalling in adrenal cortex zonation and prevents malignant tumour development
Drelon, C., Berthon, A., Sahut-Barnola, I., Mathieu, M., Dumontet, T., Rodriguez, S., Batisse-Lignier, M., Tabbal, H., Tauveron, I., Lefrançois-Martinez, A.-M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12751 · Cited by 128 · see citing works
Self-citation
Wnt/β-catenin signalling in adrenal physiology and tumour development
Berthon, A., Martinez, A., Bertherat, J., & Val, P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.009 · Cited by 125 · see citing works
Carney complex and McCune Albright syndrome: An overview of clinical manifestations and human molecular genetics
Salpea, P., & Stratakis, C. A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.08.022 · Cited by 121 · see citing works
Self-citation
Inactivation of theAPCGene Is Constant in Adrenocortical Tumors from Patients with Familial Adenomatous Polyposis but Not Frequent in Sporadic Adrenocortical Cancers
Gaujoux, S., Pinson, S., Gimenez‐Roqueplo, A., Amar, L., Ragazzon, B., Launay, P., Méatchi, T., Libé, R., BERTAGNA, X. Y., Audebourg, A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1497 · Cited by 121 · see citing works
Clinical and molecular genetics of Carney complex
Rothenbühler, A., & Stratakis, C. A. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.03.003 · Cited by 110 · see citing works
Self-citation
New targets and therapeutic approaches for endocrine malignancies☆
Fassnacht, M., Kreissl, M. C., Weismann, D., & Allolio, B. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.013 · Cited by 104 · see citing works
Management of endocrine disease: differential diagnosis, investigation and therapy of bilateral adrenal incidentalomas
Bourdeau, I., El Ghorayeb, N., Gagnon, N., & Lacroix, A. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0296 · Cited by 98 · see citing works
Self-citation
MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics
Schernthaner-Reiter, M. H., Trivellin, G., & Stratakis, C. A. (2015) · Neuroendocrinology · doi:10.1159/000371819 · Cited by 98 · see citing works
Self-citation
Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes
Rodríguez, F. J., Stratakis, C. A., & Evans, D. G. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0935-7 · Cited by 83 · see citing works
Self-citation
Steroidogenesis—Adrenal Cell Signal Transduction
Gallo‐Payet, N., & Battista, M. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130050 · Cited by 83 · see citing works
How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?
Almeida, M. Q., & Stratakis, C. A. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.11.018 · Cited by 82 · see citing works
Self-citation
A large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer
Anselmo, J., Medeiros, S., Carneiro, V., Greene, E., Levy, I., Nesterova, M., Lyssikatos, C., Horvath, A., Carney, J. A., & Stratakis, C. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2244 · Cited by 81 · see citing works
Self-citation
Genetics of tumors of the adrenal cortex
Bonnet-Serrano, F., & Bertherat, J. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0361 · Cited by 80 · see citing works
Carney complex and other conditions associated with micronodular adrenal hyperplasias
Almeida, M. Q., & Stratakis, C. A. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.006 · Cited by 80 · see citing works
Self-citation
Activation of Cyclic AMP Signaling Leads to Different Pathway Alterations in Lesions of the Adrenal Cortex Caused by Germline PRKAR1A Defects versus Those due to Somatic GNAS Mutations
Almeida, M. Q., Azevedo, M. F., Xekouki, P., Bimpaki, E. I., Horvath, A., Collins, M. T., Karaviti, L. P., Jeha, G. S., Bhattacharyya, N., Cheadle, C., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3000 · Cited by 72 · see citing works
Self-citation
Adrenocortical tumorigenesis: Lessons from genetics
Kamilaris, C. D. C., Hannah‐Shmouni, F., & Stratakis, C. A. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101428 · Cited by 71 · see citing works
Self-citation
Adrenocortical neoplasia: evolving concepts in tumorigenesis with an emphasis on adrenal cortical carcinoma variants
de Krijger, R. R., & Papathomas, T. G. (2011) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-011-1166-y · Cited by 67 · see citing works
REVIEW PAPER: Origin and Molecular Pathology of Adrenocortical Neoplasms
Bielińska, M., Parviainen, H., Kiiveri, S., Heikinheimo, M., & Wilson, D. B. (2009) · Veterinary Pathology · doi:10.1354/vp.08-vp-0179-w-rev · Cited by 67 · see citing works
What Did We Learn from the Molecular Biology of Adrenal Cortical Neoplasia? From Histopathology to Translational Genomics
Juhlin, C. C., Bertherat, J. Y., Giordano, T. J., Hammer, G. D., Sasano, H., & Mete, Ö. (2021) · Endocrine Pathology · doi:10.1007/s12022-021-09667-0 · Cited by 63 · see citing works
The cAMP pathway and the control of adrenocortical development and growth
de Joussineau, C., Sahut‐Barnola, I., Levy, I., Saloustros, E. S., Val, P., Stratakis, C. A., & Martinez, A. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.006 · Cited by 62 · see citing works
Self-citation
Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/− or Rb1+/− backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signaling
Almeida, M. Q., Muchow, M., Boikos, S. A., Bauer, A. J., Griffin, K., Tsang, K. M., Cheadle, C., Watkins, T., Wen, F., Starost, M. F., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq014 · Cited by 59 · see citing works
Self-citation
Pathogenesis of adrenocortical cancer
Bertherat, J. Y., & BERTAGNA, X. Y. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.006 · Cited by 55 · see citing works
Cushing Syndrome in Carney Complex
Lowe, K. M., Young, W. F., Lyssikatos, C., Stratakis, C. A., & Carney, J. A. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000748 · Cited by 54 · see citing works
Self-citation
Adrenal cortex tissue homeostasis and zonation: A WNT perspective
Drelon, C., Berthon, A. S., Mathieu, M., Martinez, A., & Val, P. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.12.014 · Cited by 52 · see citing works
Integrated Genomic Analysis of Nodular Tissue in Macronodular Adrenocortical Hyperplasia: Progression of Tumorigenesis in a Disorder Associated with Multiple Benign Lesions
Almeida, M. Q., Harran, M. D., Bimpaki, E. I., Hsiao, H., Horvath, A., Cheadle, C., Watkins, T., Nesterova, M., & Stratakis, C. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2420 · Cited by 51 · see citing works
Self-citation
Adrenocortical hyperplasia: A multifaceted disease
Bourdeau, I., Parisien-La Salle, S., & Lacroix, A. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101386 · Cited by 48 · see citing works
Self-citation
Genetic aspects of adrenocortical tumours and hyperplasias
Mazzuco, T. L., Durand, J., Chapman, A., Crespigio, J., & Bourdeau, I. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04403.x · Cited by 47 · see citing works
Self-citation
Role of unilateral adrenalectomy in bilateral adrenal hyperplasias with Cushing’s syndrome
Meloche‐Dumas, L., Mercier, F., & Lacroix, A. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101486 · Cited by 47 · see citing works
Pathophysiological aspects of Wnt-signaling in endocrine disease
Schinner, S., Willenberg, H. S., Schott, M., & Scherbaum, W. A. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0831 · Cited by 47 · see citing works
Primary Aldosteronism
Funder, J. W. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12935 · Cited by 46 · see citing works
The Genetics of Adrenocortical Tumors
Espiard, S., & Bertherat, J. Y. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.004 · Cited by 42 · see citing works
cAMP/PKA signaling defects in tumors: Genetics and tissue-specific pluripotential cell-derived lesions in human and mouse
Stratakis, C. A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.015 · Cited by 38 · see citing works
Self-citation
Hormonal, Radiological, NP-59 Scintigraphy, and Pathological Correlations in Patients With Cushing's Syndrome Due to Primary Pigmented Nodular Adrenocortical Disease (PPNAD)
Vezzosi, D., Tenenbaum, F., Cazabat, L., Tissier, F., Bienvenu, M., Carrasco, C. A., Laloi-Michelin, M., Barrande, G., Lefèbvre, H., Hiéronimus, S., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2174 · Cited by 38 · see citing works
Molecular Genetic and Genomic Alterations in Cushing’s Syndrome and Primary Aldosteronism
Kamilaris, C. D. C., Stratakis, C. A., & Hannah‐Shmouni, F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.632543 · Cited by 36 · see citing works
Self-citation
Alterations of Phosphodiesterases in Adrenocortical Tumors
Hannah‐Shmouni, F., Faucz, F. R., & Stratakis, C. A. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00111 · Cited by 36 · see citing works
Self-citation
Molecular Basis of Primary Aldosteronism and Adrenal Cushing Syndrome
Vaduva, P., Bonnet-Serrano, F., & Bertherat, J. Y. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa075 · Cited by 35 · see citing works
The molecular basis of adrenocortical cancer
Lehmann, T. P., & Wrzesiński, T. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.02.009 · Cited by 34 · see citing works
Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia
Penny, M. K., Finco, I., & Hammer, G. D. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.12.005 · Cited by 31 · see citing works
Bilateral Adrenal Hyperplasia: Pathogenesis and Treatment
Chevalier, B., Vantyghem, M., & Espiard, S. (2021) · Biomedicines · doi:10.3390/biomedicines9101397 · Cited by 30 · see citing works
Adrenocortical carcinoma in patients with MEN1: a kindred report and review of the literature
Wang, W., Han, R., Ye, L., Xie, J., Tao, B., Sun, F., Zhuo, R., Chen, X., Deng, X., Ye, C., et al. (2019) · Endocrine Connections · doi:10.1530/ec-18-0526 · Cited by 29 · see citing works
Identification of Genetic Alterations ofAXIN2Gene in Adrenocortical Tumors
Chapman, A., Durand, J., Ouadi, L., & Bourdeau, I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2987 · Cited by 28 · see citing works
Self-citation
Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome
Hofland, J., de Herder, W. W., Derks, L., Hofland, L. J., van Koetsveld, P. M., de Krijger, R. R., van Nederveen, F. H., Horvath, A., Stratakis, C. A., de Jong, F. H., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0594 · Cited by 26 · see citing works
Self-citation
Genetics of micronodular adrenal hyperplasia and Carney complex
Tirosh, A., Valdés, N., & Stratakis, C. A. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2018.07.005 · Cited by 26 · see citing works
Self-citation
Cushing´s syndrome due to bilateral adrenal cortical disease: Bilateral macronodular adrenal cortical disease and bilateral micronodular adrenal cortical disease
Castro, M. A., & Marazuela, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.913253 · Cited by 23 · see citing works
Phosphodiesterases and Adrenal Cushing in Mice and Humans
Szarek, E., & Stratakis, C. A. (2014) · Hormone and Metabolic Research · doi:10.1055/s-0034-1389916 · Cited by 21 · see citing works
Self-citation
Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor
Mitsui, Y., Yasumoto, H., Nagami, T., Hiraki, M., Arichi, N., Ishikawa, N., Araki, A., Maruyama, R., Tanaka, Y., Dahiya, R., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1889 · Cited by 20 · see citing works
Genetic Alterations in Benign Adrenal Tumors
Pitsava, G., & Stratakis, C. A. (2022) · Biomedicines · doi:10.3390/biomedicines10051041 · Cited by 20 · see citing works
Self-citation
Update on primary micronodular bilateral adrenocortical diseases
Maillet, M., Bourdeau, I., & Lacroix, A. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000538 · Cited by 17 · see citing works
Self-citation
Low Protein Expression of both ATRX and ZNRF3 as Novel Negative Prognostic Markers of Adult Adrenocortical Carcinoma
Balderrama-Brondani, V., Lacombe, A. M. F., Mariani, B. M. P., Montenegro, L. R., Soares, I. C., Neto, J. E. B., Tanno, F. Y., Srougi, V., Chambo, J. L., Mendonca, B. B., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031238 · Cited by 17 · see citing works
Rare diseases in clinical endocrinology: a taxonomic classification system
Marcucci, G., Cianferotti, L., Beck‐Peccoz, P., Capezzone, M., Cetani, F., Colao, A., Davì, M. V., Uberti, E. C. D., Prato, S. D., Elisei, R., et al. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0202-6 · Cited by 15 · see citing works
Primary Pigmented Nodular Adrenocortical Disease
Carney, J. A., Libé, R., Bertherat, J. Y., & Young, W. F. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000220 · Cited by 14 · see citing works
Insights into the role of genetic alterations in adrenocortical tumorigenesis
Herbet, M., Feige, J., & Thomas, M. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.010 · Cited by 13 · see citing works
Disorders of the adrenal cortex: Genetic and molecular aspects
Pitsava, G., Maria, A. G., & Faucz, F. R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.931389 · Cited by 13 · see citing works
The clinical characteristics and pathogenic variants of primary pigmented nodular adrenocortical disease in 210 patients: a systematic review
Sun, J., Ding, L., He, L., Fu, H., Li, R., Feng, J., Dong, J., & Liao, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1356870 · Cited by 12 · see citing works
The Transcriptome that Mediates Increased Cyclic Adenosine Monophosphate Signaling in Prkar1a Defects and Other Settings
Azevedo, M. F., & Stratakis, C. A. (2011) · Endocrine Practice · doi:10.4158/ep10412.ra · Cited by 12 · see citing works
Self-citation
ARMC5 variants in PRKAR1A-mutated patients modify cortisol levels and Cushing’s syndrome
Maria, A. G., Tatsi, C., Berthon, A. S., Drougat, L., Settas, N., Hannah‐Shmouni, F., Bertherat, J. Y., Faucz, F. R., & Stratakis, C. A. (2020) · Endocrine Related Cancer · doi:10.1530/erc-20-0273 · Cited by 12 · see citing works
Self-citation
First Somatic PRKAR1A Defect Associated With Mosaicism for Another PRKAR1A Mutation in a Patient With Cushing Syndrome
Kamilaris, C. D. C., Faucz, F. R., Andriessen, V. C., Nilubol, N., Lee, C. R., Ahlman, M. A., Hannah‐Shmouni, F., & Stratakis, C. A. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab007 · Cited by 10 · see citing works
Self-citation
Adrenocortical Growth and Cancer
Lefèvre, L., Bertherat, J. Y., & Ragazzon, B. (2014) · Comprehensive physiology · doi:10.1002/cphy.c140010 · Cited by 10 · see citing works
Treatment of Primary Pigmented Nodular Adrenocortical Disease
Gang, X., Wang, G., Liu, X., Zhang, S., & Guo, Y. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1948-6990 · Cited by 9 · see citing works
Adrenocortical Carcinoma
Soon, P. S. H., & Sidhu, S. B. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0857-5_11 · Cited by 9 · see citing works
Cushing's Syndrome in an Infant Secondary to Malignant Adrenocortical Tumors with Somatic Mutation of Beta-Catenin
Pusantisampan, T., Sangkhathat, S., Kayasut, K., Kanngurn, S., Jaruratanasirikul, S., Chotsampancharoen, T., & Kritsaneepaiboon, S. (2009) · Pediatric and Developmental Pathology · doi:10.2350/09-07-0683-cr.1 · Cited by 9 · see citing works
Pathogenesis of benign adrenocortical tumors
Vezzosi, D., Bertherat, J. Y., & Groussin, L. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.005 · Cited by 7 · see citing works
Phenotypic Variability in a Family with Carney Complex Accompanied by a Novel Mutation Involving PRKAR1A
Kubo, H., Tsurutani, Y., Sugisawa, C., Sunouchi, T., Hirose, R., & Saito, J. (2022) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.2022.j051 · Cited by 5 · see citing works
Molecular and Genetics Perspectives on Primary Adrenocortical Hyperfunction Disorders
Kim, S., Chaudhary, P. K., & Kim, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111341 · Cited by 4 · see citing works
Adrenal Cortex Tumors and Hyperplasias
Pignatelli, D. (2011) · InTech eBooks · doi:10.5772/19108 · Cited by 4 · see citing works
Endothelial cells regulate β -catenin activity in adrenocortical cells via secretion of basic fibroblast growth factor
Schwafertz, C., Schinner, S., Kühn, M. C., Haase, M., Asmus, A., Mülders-Opgenoorth, B., Ansurudeen, I., Hornsby, P. J., Morawietz, H., Oetjen, E., et al. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.015 · Cited by 3 · see citing works
PPNAD, Carney Complex, and Other Micronodular Adrenal Hyperplasia
Espiard, S., & Bertherat, J. Y. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64321-0 · Cited by 3 · see citing works
WNT pathway deregulation in adrenal cortex tumorigenesis
Wilmouth, J., Olabe, J., Roucher‐Boulez, F., & Val, P. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.08.016 · Cited by 2 · see citing works
Pathophysiology and Genetic Landscape of Adrenocortical Tumors and Hyperplasias
Ghorayeb, N. E., Bourdeau, I., & Lacroix, A. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_7 · Cited by 2 · see citing works
Self-citation
Identification of Cushing's syndrome (CS) and its history from Harvey Cushing to today
Poirier, J., Martel‐Duguech, L., Bourdeau, I., & Lacroix, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-96100-4.00012-0 · Cited by 1 · see citing works
Self-citation
A Novel PRKAR1A Gene Mutation Associated With Primary Pigmented Nodular Adrenocortical Disease
Ran, H., Ma, X., Wang, Q., Xie, Z., & Qin, G. (2014) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000296 · Cited by 1 · see citing works
WNT/β-Catenin Signaling in Adrenocortical Carcinoma
Gaujoux, S., Tissier, F., & Bertherat, J. Y. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_16 · Cited by 1 · see citing works
Quoi de neuf en pathologie corticosurrénalienne bilatérale ?
Tissier, F. (2008) · Annales de Pathologie · doi:10.1016/j.annpat.2008.09.008 · Cited by 1 · see citing works
Genetics of Benign Adrenocortical Tumors
Hannah‐Shmouni, F., & Stratakis, C. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-44136-8_3 · Cited by 1 · see citing works
Self-citation
New Strategies for the Treatment of Adrenocortical Carcinoma
Kirschner, L. S. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_30
PDE11A (phosphodiesterase 11A)
Libé, R., & Bertherat, J. Y. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/44886
Benign and Malignant Diseases of the Adrenal Cortex
McNicol, A. M. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-1707-2_21
Local Control of Steroid Hormone Biosynthesis
Hofland, J. (2012) · EUR Research Repository (Erasmus University Rotterdam)
Detection of somatic β-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD)
SCHTEINGART, D. E. (2009) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(09)79408-9
Genetics of Adrenocortical Cancers
Assié, G., & Bertherat, J. Y. (2016) · Springer eBooks · doi:10.1007/978-3-319-44136-8_4
21and Malignant Diseases of the Adrenal Cortex
Couvelard, A. (2010)
Molecular Pathogenesis of Primary Adrenal Cushing’s Syndrome
Ghorayeb, N. E., Bourdeau, I., & Lacroix, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_4
Self-citation
Somatic β-Catenin Gene Mutations and WNT Signaling in Adrenal Tumors
Bourdeau, I. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64311-8
Self-citation
Adrenal Neoplasms
Phan, A. T., Habra, M. A., Grubbs, E. G., & Moran, C. A. (2012) · Wiley eBooks · doi:10.1002/9781118464557.ch10
Primary Pigmented Nodular Adrenocortical Disease
Nosé, V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52480-3.50088-3
Adrenal Cortical Hyperplasia
Nosé, V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52480-3.50077-9
Molecular tools for diagnosing diseases of the adrenal cortex
Faucz, F. R., Maria, A. G., & Stratakis, C. A. (2023) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000809
Self-citation
The Hormonal Status Comparison of Unilateral and Bilateral Adrenal Adenomas: Are They the Same?
Özbaş, B., Canpolat, A. G., Özbaş, C., Çorapçıoğlu, D., & Şahi̇n, M. (2023) · European Journal of Therapeutics · doi:10.58600/eurjther665
PPNAD, Carney complex, and other micronodular adrenal hyperplasia
Vaduva, P., Espiard, S., & Bertherat, J. Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00124-2
Adrenal Cortical Nodular Diseases
(2024) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477473-04
Somatic β-catenin gene mutations and WNT signaling in adrenal tumors
Perreault, F., & Bourdeau, I. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00335-6
Self-citation
Rôle de la voie Wnt/ßcaténine dans la physiopathologie de la cortico-surrénale
Berthon, A. S. (2012) · doi:10.70675/f153e745z2e77z4090zac69zb5d4866fd8bf
Progression tumorale dans un modèle murin de carcinogénèse surrénalienne ciblée induite par antigène T de SV 40 : Recherche de cibles thérapeutiques pour le corticosurrénalome.
Batisse‐Lignier, M. (2016) · theses.fr (ABES) · doi:10.70675/da93a26ez9c9fz48f8z99a6zb56d09dc5df6

PRKAR1A mutations in primary pigmented nodular adrenocortical disease
Cazabat, L., Ragazzon, B., Groussin, L., & Bertherat, J. Y. (2006) · Pituitary · doi:10.1007/s11102-006-0266-1 · Cited by 67 · see citing works
A Novel PRKAR1A Gene Mutation Associated With Primary Pigmented Nodular Adrenocortical Disease
Ran, H., Ma, X., Wang, Q., Xie, Z., & Qin, G. (2014) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000296 · Cited by 1 · see citing works
Detection of new potentially pathogenic mutations in two patients with primary pigmented nodular adrenocortical disease (PPNAD) — case reports with literature review
Pasternak-Pietrzak, K., Stratakis, C. A., Moszczyńska, E., Lecka-Ambroziak, A., Staniszewski, M., Wątrobińska, U., Lyssikatos, C., Prokop-Piotrkowska, M., Grajkowska, W., Pronicki, M., et al. (2018) · Endokrynologia Polska · doi:10.5603/ep.a2018.0063 · Cited by 6 · see citing works
Self-citation
Wnt/β-catenin and 3′,5′-cyclic adenosine 5′-monophosphate/protein kinase A signaling pathways alterations and somatic β-catenin gene mutations in the progression of adrenocortical tumors
Gaujoux, S., Tissier, F., Groussin, L., Libé, R., Ragazzon, B., Launay, P., Audebourg, A., Dousset, B., Bertagna, X., & Bertherat, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0631 · Cited by 142 · see citing works
Mutations of thePRKAR1AGene in Cushing’s Syndrome due to Sporadic Primary Pigmented Nodular Adrenocortical Disease
Groussin, L., Jullian, E. H., Perlemoine, K., Louvel, A., Leheup, B., LUTON, J. P., BERTAGNA, X. Y., & Bertherat, J. Y. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020592 · Cited by 168 · see citing works

Authors: Tadjine, M., Lampron, A., Ouadi, L., Horvath, A., Stratakis, C. A., & Bourdeau, I.
Affiliations: Centre Hospitalier de l’Université de Montréal (CA)
National Institutes of Health (US)
Corresponding author: Bourdeau, Isabelle
ORCID: Lampron, Antoine
Stratakis, Constantine A.
Bourdeau, Isabelle
Venue: Clinical Endocrinology
Publisher: Wiley
Published: 2008-08-13
Volume: 69
Issue: 3
Pages: 367-373
ISSN: 0300-0664 (ISSN-L)
1365-2265
DOI: 10.1111/j.1365-2265.2008.03273.x
PMC: PMC3138207
OpenAlex: W2089127970
Cited by: 108
References: 27
Citations by year: 2026: 5 · 2024: 4 · 2023: 3 · 2022: 5 · 2021: 7 · 2020: 5 · 2019: 3 · 2018: 6 · 2017: 3 · 2016: 9 · 2015: 4 · 2014: 9 · 2013: 4 · 2012: 8
FWCI: 11.59
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Clinical Endocrinology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development (ZIAHD000642)
Topics: Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Keywords: Cushing's syndrome, Wnt/β-catenin signaling, adrenal adenoma, Carney complex, PRKAR1A mutation, nuclear β-catenin
MeSH terms: Adenoma, Adolescent, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adult, Child, Child, Preschool, DNA Mutational Analysis, Female, Genetic Testing, Humans, Male, Middle Aged, Mutation, Phosphoric Diester Hydrolases, Pigmentation Disorders, 3',5'-Cyclic-GMP Phosphodiesterases, beta Catenin, Cyclic AMP-Dependent Protein Kinase RIalpha Subunit, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Detection of somatic β-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD)

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks